Welcome to the international HTA database

Showing [16517 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Single-bed versus multi-bed rooms for the prevention of hospital acquired infections: clinical effectiveness and guidelines
2013	Agency for Healthcare Research and Quality (AHRQ)	Child exposure to trauma: comparative effectiveness of interventions addressing maltreatment
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Precautionary period for the safe handling of excreta or body fluids in patients receiving cytotoxic or antineoplastic therapy: clinical evidence and guidelines
2013	Agency for Healthcare Research and Quality (AHRQ)	Interventions for the prevention of Posttraumatic Stress Disorder (PTSD) in adults after exposure to psychological trauma
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Low-molecular weight heparins versus warfarin for the long-term prevention or treatment of deep vein thrombosis or pulmonary embolism: a review of the clinical and cost-effectiveness
2013	Agency for Healthcare Research and Quality (AHRQ)	PCA3 testing for the diagnosis and management of prostate cancer
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Retesting patients with sleep apnea: guidelines and recommendations
2013	NIHR Health Technology Assessment programme	Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis
2013	Agency for Healthcare Research and Quality (AHRQ)	Allergen-specific immunotherapy for the treatment of allergic rhinoconjunctivitis and/or asthma: comparative effectiveness review
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Hydroxyethyl starch versus other plasma volume expanders: a review of the clinical and cost-effectiveness, and guidelines for use
2013	Agency for Healthcare Research and Quality (AHRQ)	Strategies to prevent weight gain among adults
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Forced air warming units for adults undergoing surgery: clinical evidence
2013	Agency for Healthcare Research and Quality (AHRQ)	Primary care management of abnormal uterine bleeding
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Low molecular weight heparins versus new oral anticoagulants for long-term thrombosis prophylaxis and long-term treatment of DVT and PE: a review of the clinical and cost-effectiveness
2013	Scottish Health Technologies Group (SHTG)	Are silver dressings clinically effective and cost effective for the healing of infected wounds and the prevention of wound infection relative to other types of dressing?
2013	Agency for Healthcare Research and Quality (AHRQ)	Interventions for feeding and nutrition in cerebral palsy
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Long-acting beta-agonists and inhaled corticosteroids for treatment of chronic obstructive pulmonary disease: a review of the clinical efficacy and cost-effectiveness
2013	National Institute for Health and Care Excellence (NICE)	Percutaneous closure of patent foramen ovale to prevent recurrent cerebral embolic events. NICE interventional procedures guidance 472
2013	Scottish Health Technologies Group (SHTG)	Does the addition of positron emission tomography/computed tomography (PET/CT) to the routine investigation and assessment of patients with sarcoidosis yield clinical and economic benefits?
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Non-pharmacological therapies for the treatment of insomnia in adults: clinical evidence and guidelines
2013	Health Council of the Netherlands Gezondheidsraad (GR)	Population Screening Act: mammography in two directions as standard
2013	National Institute for Health and Care Excellence (NICE)	Uterine artery embolisation for treating adenomyosis. NICE interventional procedures guidance 473
2013	Scottish Health Technologies Group (SHTG)	What is the clinical and cost effectiveness of dynamic elastomeric fabric orthoses (DEFOs) for cerebral palsy?
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Sleep medications for adults diagnosed with insomnia: clinical evidence and harms
2013	Health Council of the Netherlands Gezondheidsraad (GR)	Population Screening Act: calcium score and the risk of cardiovascular disease
2013	National Institute for Health and Care Excellence (NICE)	Negative pressure wound therapy for the open abdomen. NICE interventional procedures guidance 467
2013	Scottish Health Technologies Group (SHTG)	Can wrist splints or steroid injections reduce the need for decompression surgery in carpal tunnel syndrome?
2013	Health Council of the Netherlands Gezondheidsraad (GR)	Population Screening Act: national population screening programme for bowel cancer
2013	National Institute for Health and Care Excellence (NICE)	Phrenic nerve transfer in brachial plexus injury. NICE interventional procedures guidance 468
2013	Scottish Health Technologies Group (SHTG)	What is the sensitivity and specificity of PET/CT compared with other diagnostic imaging modalities in determining the cause of pyrexia of unknown origin (PUO)? What is the clinical and cost effectiveness of PET/CT as a first-line investigation in patients with PUO?
2013	Health Council of the Netherlands Gezondheidsraad (GR)	Population Screening Act: Continuing a population screening trial
2013	National Institute for Health and Care Excellence (NICE)	Implantation of a duodenal–jejunal bypass sleeve for managing obesity. NICE interventional procedures guidance 471
2013	Health Council of the Netherlands Gezondheidsraad (GR)	The individual, collective and public importance of vaccination
2013	National Institute for Health and Care Excellence (NICE)	Photochemical corneal collagen cross-linkage using riboflavin and ultraviolet A for keratoconus and keratectasia. NICE interventional procedures guidance 466
2013	Scottish Health Technologies Group (SHTG)	What is the clinical effectiveness, cost effectiveness and implications for safety of assessing anti-tumour necrosis factor (TNF)α drug levels and antibodies in children with moderate to severe inflammatory bowel disease compared with existing clinical strategies in use in NHS Scotland?
2013	Health Council of the Netherlands Gezondheidsraad (GR)	Vaccination of infants against pneumococcal infections (3)
2013	National Institute for Health and Care Excellence (NICE)	Endoscopic radiofrequency ablation for gastro-oesophageal reflux disease. NICE interventional procedures guidance 461
2013	Scottish Health Technologies Group (SHTG)	PET/CT for the inversitgation of paraneoplastic syndromes (PNS)
2013	Health Council of the Netherlands Gezondheidsraad (GR)	Population Screening Act: bowel cancer screening by pill camera
2013	National Institute for Health and Care Excellence (NICE)	Translaryngeal tracheostomy. NICE interventional procedures guidance 462
2013	NIHR Health Technology Assessment programme	Echocardiography in newly diagnosed atrial fibrillation patients: a systematic review and economic evaluation
2013	Scottish Health Technologies Group (SHTG)	Is patient self-monitoring (including self-testing and self-management) of oral anticoagulation therapy safe, efficacious, and cost effective? (update of EN 27)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Transcatheter aortic valve replacement in severe aortic stenosis: a review of comparative durability and clinical effectiveness beyond 12 months
2013	Health Council of the Netherlands Gezondheidsraad (GR)	NIPT: dynamics and ethics of prenatal screening
2013	National Institute for Health and Care Excellence (NICE)	Insertion of customised exposed titanium implants, without soft tissue cover, for complex orofacial reconstruction. NICE interventional procedures guidance 457
2013	NIHR Health Technology Assessment programme	The effectiveness and cost-effectiveness of acupressure for the control and management of chemotherapy-related acute and delayed nausea: Assessment of Nausea in Chemotherapy Research (ANCHoR), a randomised controlled trial
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Screening for sexually transmitted infections: a review of guidelines
2013	Health Council of the Netherlands Gezondheidsraad (GR)	Population Screening Act: noninvasive prenatal test for increased risk of trisomy
2013	HTA Unit, University of Calgary	Use of Oncotype DX for guiding adjuvant chemotherapy decisions in early stage invasive breast cancer patients in Alberta
2013	National Institute for Health and Care Excellence (NICE)	Selective internal radiation therapy for primary hepatocellular carcinoma. NICE interventional procedures guidance 460
2013	Scottish Health Technologies Group (SHTG)	What is the evidence for the clinical and cost effectiveness of major trauma centres as the core component of a trauma service, compared with standard care for adults with major trauma?
2013	Agency for Healthcare Research and Quality (AHRQ)	Update on emerging genetic tests currently available for clinical use in common cancers
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Brentuximab for refractory CD30+ Hodgkin's lymphoma: clinical and cost-effectiveness
2013	National Institute for Health and Care Excellence (NICE)	Insertion of customised titanium implants, with soft tissue cover, for orofacial reconstruction. NICE interventional procedures guidance 449
2013	Scottish Health Technologies Group (SHTG)	Is cone beam computed tomography (CBCT) clinically effective, cost-effective and safe compared with standard extraoral and intraoral radiography in the diagnosis of hard tissue pathology in routine dental practice?
2013	Agency for Healthcare Research and Quality (AHRQ)	Making health care safer II: an updated critical analysis of the evidence for patient safety practices
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Administration of anesthesia by anesthesiologists versus non-physicians for patients undergoing cataract surgery: clinical effectiveness, cost-effectiveness, and guidelines
2013	National Institute for Health and Care Excellence (NICE)	Occipital nerve stimulation for intractable chronic migraine. NICE interventional procedures guidance 452
2013	Agency for Healthcare Research and Quality (AHRQ)	Screening for suicide risk in primary care: a systematic evidence review for the U.S. Preventive Services Task Force.
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Standing tables for adults with cerebral palsy: a review of the clinical evidence
2013	National Institute for Health and Care Excellence (NICE)	Corneal inlay implantation for correction of presbyopia. NICE interventional procedures guidance 455
2013	NIHR Health Technology Assessment programme	MAGNEsium Trial In Children (MAGNETIC): a randomised, placebo controlled trial and economic evaluation of nebulised magnesium sulphate in acute severe asthma in children
2013	Agency for Healthcare Research and Quality (AHRQ)	Screening for oral cancer: a targeted evidence update for the U.S. Preventive Services Task Force
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Tools and devices for the management of dementia in older adults: review of evidence-based guidelines
2013	Malaysian Health Technology Assessment (MaHTAS)	Intraocular lens (IOL) implantation and opacification – an update
2013	National Institute for Health and Care Excellence (NICE)	Electrochemotherapy for metastases in the skin from tumours of non-skin origin and melanoma. NICE interventional procedures guidance 446
2013	Agency for Healthcare Research and Quality (AHRQ)	Assessment and management of chronic cough
2013	Agency for Healthcare Research and Quality (AHRQ)	The ankle brachial index for peripheral artery disease screening and cardiovascular disease prediction in asymptomatic adults: a systematic evidence review for the U.S. Preventive Services Task Force
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Beta human chorionic gonadotropin test for detection of early pregnancy: clinical effectiveness, cost-effectiveness, and guidelines
2013	Institute of Health Economics (IHE)	Islet transplantation for the treatment of type 1 diabetes [update]
2013	Malaysian Health Technology Assessment (MaHTAS)	Collagen for anti aging treatment, enhance cell regeneration and boosting the immune system
2013	National Institute for Health and Care Excellence (NICE)	Insertion of endobronchial valves for persistent air leaks. NICE interventional procedures guidance 448
2013	NIHR Health Technology Assessment programme	Randomised Assessment of Treatment using Panel Assay of Cardiac markers - Contemporary Biomarker Evaluation (RATPAC CBE)
2013	Agency for Healthcare Research and Quality (AHRQ)	Outpatient case management for adults with medical illness and complex care needs
2013	Scottish Health Technologies Group (SHTG)	What approaches have been taken and efforts made to ensure public involvement in decision making relating to potential disinvestment in healthcare interventions and technologies?
2013	Agency for Healthcare Research and Quality (AHRQ)	Screening for hypertension in children and adolescents to prevent cardiovascular disease: systematic review for the U.S. Preventive Services Task Force.
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Interventions used to determine the appropriate patient populations for cataract surgery: a review of the clinical evidence and guidelines
2013	National Institute for Health and Care Excellence (NICE)	Percutaneous electrical nerve stimulation for refractory neuropathic pain. NICE interventional procedures guidance 450
2013	NIHR Health Technology Assessment programme	The effectiveness and cost-effectiveness of acupressure for the control and management of chemotherapy-related acute and delayed nausea: Assessment of Nausea in Chemotherapy Research (ANCHoR), a randomised controlled trial
2013	Agency for Healthcare Research and Quality (AHRQ)	Child and adolescent exposure to trauma: comparative effectiveness of interventions addressing trauma other than maltreatment or family violence
2013	Agency for Healthcare Research and Quality (AHRQ)	Behavioral interventions and counseling to prevent child abuse and neglect: systematic review to update the U.S. Preventive Services Task Force Recommendation.
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Antimicrobial drapes for the reduction of surgical site infection: clinical effectiveness
2013	National Institute for Health and Care Excellence (NICE)	Peripheral nerve-field stimulation for chronic low back pain. NICE interventional procedures guidance 451
2013	Agency for Healthcare Research and Quality (AHRQ)	Intravascular diagnostic procedures and imaging techniques versus angiography alone in coronary artery stenting: comparative effectiveness review
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Compression bandage measurement devices for the use in adult patients with chronic venous insufficiency: clinical effectiveness
2013	Agenzia nazionale per i servizi sanitari regionali (Agenas)	Implantable devices for the closure of patent foramen ovale (PFO) in adults. Rapid HTA report
2013	Malaysian Health Technology Assessment (MaHTAS)	Negative pressure wound therapy (Renasys Go Console Package)
2013	National Institute for Health and Care Excellence (NICE)	Irreversible electroporation for treating primary lung cancer and metastases in the lung. NICE interventional procedures guidance 441
2013	NIHR Health Technology Assessment programme	Development of DEMQOL-U and DEMQOL-PROXY-U: generation of preference-based indices from DEMQOL and DEMQOL-PROXY for use in economic evaluation
2013	Agency for Healthcare Research and Quality (AHRQ)	Insulin delivery and glucose monitoring methods: future research needs
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Eribulin mesilate (Halaven) for advanced non-small cell lung cancer – third line
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Techniques for renal biopsy: guidelines
2013	Norwegian Knowledge Centre for the Health Services (NOKC)	Health technology assessment of the different dialysis modalities in Norway
2013	Health Council of the Netherlands Gezondheidsraad (GR)	A closer look at Lyme disease
2013	Malaysian Health Technology Assessment (MaHTAS)	Photodynamic therapy for cancer treatment – an update
2013	National Institute for Health and Care Excellence (NICE)	Irreversible electroporation for treating renal cancer. NICE interventional procedures guidance 443
2013	NIHR Health Technology Assessment programme	Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review
2013	NIHR Health Technology Assessment programme	Colistimethate sodium powder and tobramycin powder for inhalation for the treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis: systematic review and economic model
2013	Agency for Healthcare Research and Quality (AHRQ)	Efficacy and safety of screening for postpartum depression
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Olaparib for relapsed platinum-sensitive ovarian cancer